PH20660A - Human proinsulin and analogs thereof and method of preparation by microbial polypeptide expression and conversion thereof to human insulin - Google Patents

Human proinsulin and analogs thereof and method of preparation by microbial polypeptide expression and conversion thereof to human insulin

Info

Publication number
PH20660A
PH20660A PH26687A PH26687A PH20660A PH 20660 A PH20660 A PH 20660A PH 26687 A PH26687 A PH 26687A PH 26687 A PH26687 A PH 26687A PH 20660 A PH20660 A PH 20660A
Authority
PH
Philippines
Prior art keywords
human
analogs
conversion
preparation
polypeptide expression
Prior art date
Application number
PH26687A
Other languages
English (en)
Inventor
David V Goeddel
Keiichi Nmi Itakura
Dennis G Kleid
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PH20660A publication Critical patent/PH20660A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
PH26687A 1981-01-02 1981-12-29 Human proinsulin and analogs thereof and method of preparation by microbial polypeptide expression and conversion thereof to human insulin PH20660A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22204481A 1981-01-02 1981-01-02

Publications (1)

Publication Number Publication Date
PH20660A true PH20660A (en) 1987-03-23

Family

ID=22830549

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26687A PH20660A (en) 1981-01-02 1981-12-29 Human proinsulin and analogs thereof and method of preparation by microbial polypeptide expression and conversion thereof to human insulin

Country Status (12)

Country Link
EP (1) EP0055945A3 (OSRAM)
JP (1) JPS57163352A (OSRAM)
KR (1) KR830007828A (OSRAM)
AU (1) AU7914581A (OSRAM)
DK (1) DK582481A (OSRAM)
ES (1) ES508446A0 (OSRAM)
FI (1) FI814172L (OSRAM)
GR (1) GR78327B (OSRAM)
IL (1) IL64634A (OSRAM)
NZ (1) NZ199391A (OSRAM)
PH (1) PH20660A (OSRAM)
ZA (1) ZA818953B (OSRAM)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
CA1204682A (en) * 1981-06-19 1986-05-20 Saran A. Narang Adaptors, and synthesis and cloning of proinsulin genes
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
FI834213A0 (fi) * 1982-03-31 1983-11-17 Genetics Inst Framstaellning av dna-sekvenser kodande foer prekursoren av modifierat proinsulin
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3716722A1 (de) * 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
DE69001248T2 (de) * 1989-05-04 1993-10-14 Genentech Inc Verfahren und zusammensetzungen zur isolation von menschlichem relaxin.
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
ATE148710T1 (de) 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
IL138658A0 (en) 1998-03-31 2001-10-31 Tonghua Gantech Biotechnology Chimeric protein
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
RU2144957C1 (ru) * 1999-02-26 2000-01-27 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pPINS07, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД, СОДЕРЖАЩИЙ ПРОИНСУЛИН ЧЕЛОВЕКА, И ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ ГИБРИДНОГО ПОЛИПЕПТИДА, СОДЕРЖАЩЕГО ПРОИНСУЛИН ЧЕЛОВЕКА
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
JP4795599B2 (ja) * 1999-12-29 2011-10-19 ノボ ノルディスク アクティーゼルスカブ 酵母において改良された発酵収率を有するインスリン前駆体及びインスリン前駆体類似体の製造方法
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
AU4935701A (en) 2000-03-24 2001-10-08 Genentech Inc Use of insulin for the treatment of cartilagenous disorders
US6821755B2 (en) * 2000-07-27 2004-11-23 Boehringer Ingelheim International Gmbh Preparation of a recombinant protein in a prokaryotic host cell
AR025646A1 (es) 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
WO2002079251A2 (en) * 2001-04-02 2002-10-10 Novo Nordisk A/S Method for making human insulin precursors
DE602004014251D1 (de) 2003-01-31 2008-07-17 Organon Nv Verfahren zur proteinisolierung unteranoxischen bedingungen
WO2007014162A2 (en) 2005-07-21 2007-02-01 Abbott Laboratories Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
MX2008003362A (es) 2005-09-14 2008-03-25 Sanofi Aventis Deutschland Escision de precursores de insulinas mediante una variante de tripsina.
JP5864834B2 (ja) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス プロテアーゼ耐性のインスリンアナログ
CN101173006B (zh) * 2006-10-30 2011-12-21 江苏万邦生化医药股份有限公司 一种重组人胰岛素的制备方法
US7790677B2 (en) 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
AU2008327513B2 (en) 2007-09-21 2012-05-03 Cadila Healthcare Limited GCSF fusion protein systems suitable for high expression of peptides
KR101775000B1 (ko) 2009-06-26 2017-09-04 노보 노르디스크 에이/에스 인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
CA2821613A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
WO2012080320A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
EP2739646B1 (en) 2011-05-10 2018-01-24 Stefan Hermann Comprehensive buffer system for renaturing human proinsulin or proinsulin derivatives
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
KR20190036956A (ko) 2017-09-28 2019-04-05 한미약품 주식회사 지속형 단쇄 인슐린 아날로그 및 이의 결합체
WO2020051812A1 (zh) 2018-09-12 2020-03-19 美药星（南京）制药有限公司 一种新型门冬胰岛素原的结构和制备门冬胰岛素的方法
CN119529057A (zh) 2019-12-30 2025-02-28 甘李药业股份有限公司 长效glp-1化合物
BR112022013150A2 (pt) 2019-12-30 2023-02-28 Gan & Lee Pharmaceuticals Co Ltd Derivado da insulina
EP4471053A1 (en) 2022-01-28 2024-12-04 Gan & Lee Pharmaceuticals Co., Ltd. Acylated insulin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT373279B (de) * 1977-11-08 1984-01-10 Genentech Inc Verfahren zur herstellung eines rekombinationsclonbildungstraegers
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
IE48385B1 (en) * 1978-08-11 1984-12-26 Univ California Synthesis of a eucaryotic protein by a microorganism
GR70279B (OSRAM) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers

Also Published As

Publication number Publication date
DK582481A (da) 1982-08-13
AU7914581A (en) 1982-07-08
FI814172A7 (fi) 1982-07-03
EP0055945A3 (en) 1982-09-15
EP0055945A2 (en) 1982-07-14
FI814172L (fi) 1982-07-03
ES8401777A1 (es) 1984-01-01
JPS57163352A (en) 1982-10-07
ZA818953B (en) 1983-02-23
NZ199391A (en) 1985-12-13
IL64634A0 (en) 1982-03-31
KR830007828A (ko) 1983-11-07
ES508446A0 (es) 1984-01-01
GR78327B (OSRAM) 1984-09-26
IL64634A (en) 1986-03-31

Similar Documents

Publication Publication Date Title
PH20660A (en) Human proinsulin and analogs thereof and method of preparation by microbial polypeptide expression and conversion thereof to human insulin
JPS54137896A (en) Artificial valve capable of replacing with human heart valve
CS8606310A2 (en) Method of insulin's analogues production
DE3467772D1 (en) Analogs of human interleukin ii and their preparation
JPS5772959A (en) Conversion of dialkylsulfide to alkylmercaptane
AU549066B2 (en) Preparation of human insulin
GB2005537B (en) Method of preparing pellets for oral administration to ruminants
AU551733B2 (en) Human insulin and human proinsulin formulations
IL66151A0 (en) Preparation of optically pure d-or l-lactic acid by fermentation
AU551879B2 (en) Human proinsulin and human c-peptide
IL68499A0 (en) Use of thiadiazolylimidazolidinones to control aquatic vegetation
DE3262052D1 (en) Process for the enzymatic preparation of human insulin
AU551734B2 (en) Human proinsulin and human c-peptide and human insulin formulations
GB2091739B (en) Purification of human growth hormone
AU4755785A (en) Use of brassinolide to increase crop yields
HUT48907A (en) Process for production of small peptides linked to 1,4 receptors with immunogene effect and medical preparatives containing these substances
AU5598286A (en) Method of using human growth hormone to stimulate the growth of agricultural animals
JPS5519184A (en) Preparation of artificial skin
CS286788A1 (en) Method of 2, 3 to 4, 6-diisopropylidene-2-keto-l-gulonic acid preparation
SU1572511A1 (ru) Cпocoб пepeboдa бoльhыx c иckуcctbehhoгo ha camoctoяteльhoe дыxahиe
JPS57177761A (en) Mechanism for alternately carrying out transplantation of artificial heart and heart
MN218A6 (en) Method of preparing alumekatin medicinal preparation
KR780000402B1 (en) Process for preparation of 5'-inosinic acid by fermentation
IT1125435B (it) Glucosammide dell'acido p-isobutilfenilpropionico ad azione terapeutica e procedimento per la sua preparazione
AU4453585A (en) Ruffle attached to bed-base by zipper